The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer

Saved in:
Bibliographic Details
Main Authors: Schott, Annekatrin (Author) , Simon, Theresa (Author) , Müller, Simon (Author) , Rausch, Alexander (Author) , Busch, Bianca (Author) , Glaß, Markus (Author) , Misiak, Danny (Author) , Dipto, Mohammad (Author) , Elrewany, Hend (Author) , Peters, Lara Meret (Author) , Tripathee, Sunita (Author) , Ghazy, Ehab Mohamed Elbassiony (Author) , Müller, Florian (Author) , Rolnik, Robin Benedikt (Author) , Lederer, Marcell (Author) , Hmedat, Ali (Author) , Vetter, Martina (Author) , Wallwiener, Markus (Author) , Sippl, Wolfgang (Author) , Hüttelmaier, Stefan (Author) , Bley, Nadine (Author)
Format: Article (Journal)
Language:English
Published: March 2025
In: NAR: cancer
Year: 2025, Volume: 7, Issue: 1, Pages: 1-16
ISSN:2632-8674
DOI:10.1093/narcan/zcaf006
Online Access:Resolving-System, kostenfrei: https://doi.org/10.1093/narcan/zcaf006
Get full text
Author Notes:Annekatrin Schott, Theresa Simon, Simon Müller, Alexander Rausch, Bianca Busch, Markus Glaß, Danny Misiak, Mohammad Dipto, Hend Elrewany, Lara Meret Peters, Sunita Tripathee, Ehab Ghazy, Florian Müller, Robin Benedikt Rolnik, Marcell Lederer, Ali Hmedat, Martina Vetter, Markus Wallwiener, Wolfgang Sippl, Stefan Hüttelmaier, Nadine Bley
Description
Physical Description:Online Resource
ISSN:2632-8674
DOI:10.1093/narcan/zcaf006